Increased prevalence of albuminuria in HIV-infected adults with diabetes

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Kim, Peter S ^a   Woods, Christian ^b   Dutcher, Lauren ^c   Georgoff, Patrick ^c   Rosenberg, Alice ^a   Mican, Jo Ann M ^a   Kopp, Jeffrey B ^d   Smith, Margo A ^b   Hadigan, Colleen ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ALBUMIN; ATAZANAVIR; CREATININE; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; INDINAVIR; INSULIN; LAMIVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; TENOFOVIR; ZALCITABINE; ZIDOVUDINE; 2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AGE; ALBUMINURIA; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PREVALENCE; RACE DIFFERENCE; VIRUS LOAD; BLOOD PRESSURE; CD4+ T LYMPHOCYTE; GLOMERULUS FILTRATION RATE; IMMUNOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSIOLOGY;

ADULT; ALBUMINURIA; ANTI-HIV AGENTS; BLOOD PRESSURE; BODY MASS INDEX; CD4-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIDEOXYNUCLEOSIDES; FEMALE; GLOMERULAR FILTRATION RATE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS;

EID: 80052766873     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024610     Document Type: Article

References (27)

1. Schwartz EJ, Szczech LA, Ross MJ, Klotman ME, Winston JA, et al. (2005) Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease. J Am Soc Nephrol 16: 2412-2420.
2. Wyatt CM, Klotman PE, (2007) HIV-associated nephropathy in the era of antiretroviral therapy. Am J Med 120: 488-492.
3. Izzedine H, Deray G, (2007) The nephrologist in the HAART era. AIDS 21: 409-421.
4. Brown TT, Cole SR, Li X, Kingsley LA, Palella FJ, et al. (2005) Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med 165: 1179-1184.
5. De Wit S, Sabin CA, Weber R, Worm SW, Reiss P, et al. (2008) Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Diabetes Care 31: 1224-1229.
6. Ledergerber B, Furrer H, Rickenbach M, Lehmann R, Elzi L, et al. (2007) Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study. Clin Infect Dis 45: 111-119.
7. Hallan S, Astor B, Romundstad S, Aasarod K, Kvenild K, et al. (2007) Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. Arch Intern Med 167: 2490-2496.
8. Cao JJ, Barzilay JI, Peterson D, Manolio TA, Psaty BM, et al. (2006) The association of microalbuminuria with clinical cardiovascular disease and subclinical atherosclerosis in the elderly: the Cardiovascular Health Study. Atherosclerosis 187: 372-377.
9. Arnlov J, Evans JC, Meigs JB, Wang TJ, Fox CS, et al. (2005) Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 112: 969-975.
10. Luke DR, Sarnoski TP, Dennis S, (1992) Incidence of microalbuminuria in ambulatory patients with acquired immunodeficiency syndrome. Clin Nephrol 38: 69-74.
11. Kimmel PL, Umana WO, Bosch JP, (1993) Abnormal urinary protein excretion in HIV-infected patients. Clin Nephrol 39: 17-21.
12. Baekken M, Os I, Sandvik L, Oektedalen O, (2008) Microalbuminuria associated with indicators of inflammatory activity in an HIV-positive population. Nephrol Dial Transplant 23: 3130-3137.
13. Szczech LA, Grunfeld C, Scherzer R, Canchola JA, van der Horst C, et al. (2007) Microalbuminuria in HIV infection. AIDS 21: 1003-1009.
14. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, et al. (2003) Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63: 225-232.
15. Kim PS, Woods C, Georgoff P, Crum D, Rosenberg A, et al. (2009) A1C underestimates glycemia in HIV infection. Diabetes Care 32: 1591-1593.
16. Rossi MC, Nicolucci A, Pellegrini F, Comaschi M, Ceriello A, et al. (2008) Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study. Nephrol Dial Transplant 23: 1278-1284.
17. Jones CA, Francis ME, Eberhardt MS, Chavers B, Coresh J, et al. (2002) Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 39: 445-459.
18. Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, et al. (2004) Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS 18: 541-546.
19. Glesby MJ, Hoover DR, Shi Q, Danoff A, Howard A, et al. (2010) Glycated haemoglobin in diabetic women with and without HIV infection: data from the Women's Interagency HIV Study. Antivir Ther 15: 571-577.
20. Flandre P, Pugliese P, Cuzin L, Bagnis CI, Tack I, et al. (2011) Risk Factors of Chronic Kidney Disease in HIV-infected Patients. Clin J Am Soc Nephrol 6: 1700-1707.
21. Lundgren J, Neuhaus J, Babiker A, Cooper D, Duprez D, et al. (2008) Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients. AIDS 22: F17-24.
22. Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, et al. (2008) Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. Lancet 371: 1417-1426.
23. Bedimo RJ, Westfall AO, Drechsler H, Vidiella G, Tebas P, (2011) Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era. Clin Infect Dis 53: 84-91.
24. Hsue PY, Hunt PW, Wu Y, Schnell A, Ho JE, et al. (2009) Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients. AIDS.
25. Aso Y, Yoshida N, Okumura K, Wakabayashi S, Matsutomo R, et al. (2004) Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia. Clin Chim Acta 348: 139-145.
26. Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, et al. (2002) Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 51: 1157-1165.
27. Navarro JF, Mora C, Maca M, Garca J, (2003) Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. Am J Kidney Dis 42: 53-61.